Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q8CFQ3

Entry ID Method Resolution Chain Position Source
AF-Q8CFQ3-F1 Predicted AlphaFoldDB

82 variants for Q8CFQ3

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3388570449 3 A>V No EVA
rs3388570464 14 T>S No EVA
rs3388577627 28 C>S No EVA
rs3388576069 61 I>F No EVA
rs3388576109 94 I>V No EVA
rs3392090404 108 A>G No EVA
rs216910578 117 D>E No EVA
rs28271886 121 F>S No EVA
rs232458433 125 C>R No EVA
rs28271887 134 T>A No EVA
rs3388576456 158 E>G No EVA
rs3388572032 191 P>S No EVA
rs3388583025 311 F>V No EVA
rs3388577290 322 T>I No EVA
rs28271968 346 P>S No EVA
rs3388577587 352 A>P No EVA
rs3388581640 369 F>Y No EVA
rs3388573966 478 T>I No EVA
rs3388576509 497 S>Y No EVA
rs3388576502 515 V>E No EVA
rs3388581574 518 T>S No EVA
rs3388573973 523 A>T No EVA
rs3388572327 560 D>H No EVA
rs3388576119 564 L>* No EVA
rs3388571972 586 Q>H No EVA
rs3388573544 596 E>* No EVA
rs3388577335 601 L>M No EVA
rs3388579673 636 Q>R No EVA
rs3388576441 637 D>G No EVA
rs3388570452 661 P>Q No EVA
rs3388565775 670 L>S No EVA
rs3388570458 671 E>D No EVA
rs3388573920 671 E>G No EVA
rs3388577320 688 H>Q No EVA
rs3388578158 764 A>S No EVA
rs3388573536 786 N>D No EVA
rs3388576050 821 V>I No EVA
rs3388565851 822 V>L No EVA
rs3388565851 822 V>M No EVA
rs3388573947 826 G>A No EVA
rs3388577600 833 A>T No EVA
rs3388576500 834 V>D No EVA
rs3388572298 839 N>Y No EVA
rs1132465519 844 F>L No EVA
rs1133964500 845 P>A No EVA
rs1133198204 845 P>Q No EVA
rs3388570477 861 Q>H No EVA
rs3388573546 919 L>R No EVA
rs3388565785 927 Y>* No EVA
rs226145000 954 S>T No EVA
rs241522431 956 T>S No EVA
rs3413151086 976 E>V No EVA
rs3388572312 1002 F>L No EVA
rs3392037960 1006 K>E No EVA
rs3392006664 1021 L>R No EVA
rs3391979099 1022 R>S No EVA
rs3392081216 1047 A>T No EVA
rs3391782610 1054 V>A No EVA
rs3392089523 1054 V>I No EVA
rs3392052803 1056 L>S No EVA
rs3392058272 1087 D>G No EVA
rs3391921994 1088 G>* No EVA
rs3388577657 1126 R>S No EVA
rs3388573951 1188 D>V No EVA
rs3388583037 1190 Q>* No EVA
rs3388577313 1249 C>R No EVA
rs3388580922 1252 N>D No EVA
rs3388572042 1292 R>S No EVA
rs3388565763 1293 R>G No EVA
rs3388581644 1293 R>H No EVA
rs3388579621 1295 V>G No EVA
rs3388576420 1296 V>I No EVA
rs3388576420 1296 V>L No EVA
rs3388573548 1316 N>T No EVA
rs3388581577 1319 E>G No EVA
rs3388577350 1320 L>M No EVA
rs3388579702 1329 A>V No EVA
rs3388577617 1340 E>* No EVA
rs3388581602 1352 P>S No EVA
rs3388572308 1366 A>E No EVA
rs254232066 1437 A>T No EVA
rs28286618 1438 Q>R No EVA

No associated diseases with Q8CFQ3

4 regional properties for Q8CFQ3

Type Name Position InterPro Accession
domain Intron-binding protein aquarius, N-terminal 20 - 802 IPR032174
domain DNA2/NAM7 helicase, helicase domain 802 - 1110 IPR041677
domain DNA2/NAM7 helicase-like, C-terminal 1119 - 1309 IPR041679
domain Upf1-like, C-terminal helicase domain 1144 - 1327 IPR047187

Functions

Description
EC Number 3.6.4.13 Acting on ATP; involved in cellular and subcellular movement
Subcellular Localization
  • Nucleus
  • Nucleus, nucleoplasm
  • Localizes to speckle-like regions of the nucleoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

4 GO annotations of cellular component

Name Definition
catalytic step 2 spliceosome A spliceosomal complex that contains three snRNPs, including U5, bound to a splicing intermediate in which the first catalytic cleavage of the 5' splice site has occurred. The precise subunit composition differs significantly from that of the catalytic step 1, or activated, spliceosome, and includes many proteins in addition to those found in the associated snRNPs.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
U2-type catalytic step 2 spliceosome A spliceosomal complex that contains the U2, U5 and U6 snRNPs bound to a splicing intermediate in which the first catalytic cleavage of the 5' splice site has occurred. The precise subunit composition differs significantly from that of the catalytic step 1, or activated, spliceosome, and includes many proteins in addition to those found in the U2, U5 and U6 snRNPs.

6 GO annotations of molecular function

Name Definition
3'-5' RNA helicase activity Unwinding of an RNA helix in the 3' to 5' direction, driven by ATP hydrolysis.
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
ATP hydrolysis activity Catalysis of the reaction: ATP + H2O = ADP + H+ phosphate. ATP hydrolysis is used in some reactions as an energy source, for example to catalyze a reaction or drive transport against a concentration gradient.
mRNA binding Binding to messenger RNA (mRNA), an intermediate molecule between DNA and protein. mRNA includes UTR and coding sequences, but does not contain introns.
RNA binding Binding to an RNA molecule or a portion thereof.
single-stranded RNA binding Binding to single-stranded RNA.

1 GO annotations of biological process

Name Definition
mRNA splicing, via spliceosome The joining together of exons from one or more primary transcripts of messenger RNA (mRNA) and the excision of intron sequences, via a spliceosomal mechanism, so that mRNA consisting only of the joined exons is produced.

2 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
O60306 AQR RNA helicase aquarius Homo sapiens (Human) PR
P23249 Mov10 Putative helicase MOV-10 Mus musculus (Mouse) PR
10 20 30 40 50 60
MAAPAQPKKI VAPTVSQINA EFVTQLACKY WAPHIKKKSP FDIKVIEEIY EKEIVKSRFA
70 80 90 100 110 120
IRKIMLLEFS QYLENYLWMN YSPEVSSKAY LMSICCMVNE KFRENVPAWE TFKKKPDHFP
130 140 150 160 170 180
FFFKCILKAA LAETDGEFSL HEQTLLLLFL DHCFNSLEVD LIRSQVQQLI SLPMWMGLQP
190 200 210 220 230 240
ARLELELKKT PKLRKFWNLI KKNDEKMDPE AREQAYQERR FLSRLIQKFI SVLKSIPLSE
250 260 270 280 290 300
PVTMDKVHYC ERFIELMIDL EALLPTRRWF NTILDDSHLL VHCYLSSLVH REEDGHLFSQ
310 320 330 340 350 360
LLDMLKFYTG FEINDQTGNA LTENEMTTIH YDRITSLQRA AFAHFPELYD FALSNVAEVD
370 380 390 400 410 420
ARDSLVKFFG PLSSNTLHQV ASYLCLLPTL PKNEDTTFDK EFLLELLVSR HERRISQIQQ
430 440 450 460 470 480
LNQMPLYPTE KIIWDENIVP TEYYSGEGCL ALPKLNLQFL TLHDYLLRNF NLFRLESTYE
490 500 510 520 530 540
IRQDIEDSVS RMKPWQSEYG GVVFGGWARM AQPIVAFTVV EVAKPNIGEN WPTRVRADVT
550 560 570 580 590 600
INLNVRDHIK DEWEGLRKHD VCFLITVRPT KPYGTKFDRR RPFIEQVGLV YVRGCEIQGM
610 620 630 640 650 660
LDDKGRVIED GPEPRPNLRG ESRTFRVFLD PNQYQQDMTN TIQNGAEDVY DTFNVIMRRK
670 680 690 700 710 720
PKENNFKAVL ETIRNLMNTD CVVPDWLHDI ILGYGDPSSA HYSKMPNQIA TLDFNDTFLS
730 740 750 760 770 780
IEHLKASFPG HNVKVTVSDP ALQIPPFRIT FPVRSGKGKK RKDADGEEDD TEEAKTLIVE
790 800 810 820 830 840
PHVIPNRGPY PYNQPKRNTI QFTHTQIEAI RAGMQPGLTM VVGPPGTGKT DVAVQIISNI
850 860 870 880 890 900
YHNFPEQRTL IVTHSNQALN QLFEKIMALD IDERHLLRLG HGEEELETEK DFSRYGRVNY
910 920 930 940 950 960
VLARRIELLE EVKRLQKSLG VPGDASYTCE TAGYFFLYQV MSRWEEYMSR VKNSGTACPD
970 980 990 1000 1010 1020
AAPDAAQVAT FFPFHEYFAN APQPIFKGRS YEEDMEIAEG CFRHIKKIFT QLEEFRASEL
1030 1040 1050 1060 1070 1080
LRSGLDRSKY LLVKEAKIIA MTCTHAALKR HDLVKLGFKY DNILMEEAAQ ILEIETFIPL
1090 1100 1110 1120 1130 1140
LLQNPQDGFS RLKRWIMIGD HHQLPPVIKN MAFQKYSNME QSLFTRFVRV GVPTVDLDAQ
1150 1160 1170 1180 1190 1200
GRARASLCNL YNWRYKNLGN LPHVQLLPEF STANAGLLYD FQLINVEDFQ GVGESEPNPY
1210 1220 1230 1240 1250 1260
FYQNLGEAEY VVALFMYMCL LGYPADKISI LTTYNGQKHL IRDIINRRCG NNPLIGRPNK
1270 1280 1290 1300 1310 1320
VTTVDRFQGQ QNDYILLSLV RTRAVGHLRD VRRLVVAMSR ARLGLYIFAR VSLFQNCFEL
1330 1340 1350 1360 1370 1380
TPAFSQLTAR PLHLHIIPTE PFPTSRKNGE RPPHEVQVIK NMPQMANFVY NMYMHLIQTT
1390 1400 1410 1420 1430 1440
HHYHQTFLQL PPAMVEEGEE GQSQETEMEA EEETVSAQGN LTPSPADASL SQETPAAQPD
1450 1460 1470 1480
CSSQTEDTSA PCDIATAAEP VSAAAEAATP QDAESVPTET E